Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-20,100
Closed -$2.31M 13591
2026
Q1
$2.31M Sell
20,100
-10,100
-33% -$891K ﹤0.01% 5789
2025
Q4
$1.97M Buy
30,200
+11,900
+65% +$949K ﹤0.01% 5948
2025
Q3
$1.5M Sell
18,300
-82,600
-82% -$5.95M ﹤0.01% 6671
2025
Q2
$6.64M Buy
100,900
+90,200
+843% +$5.62M ﹤0.01% 3639
2025
Q1
$702K Sell
10,700
-27,200
-72% -$1.84M ﹤0.01% 7744
2024
Q4
$2.91M Sell
37,900
-700
-2% -$60.5K ﹤0.01% 4892
2024
Q3
$3.22M Buy
38,600
+36,500
+1,738% +$2.43M ﹤0.01% 4669
2024
Q2
$116K Sell
2,100
-28,900
-93% -$1.57M ﹤0.01% 10704
2024
Q1
$2.16M Buy
31,000
+24,100
+349% +$1.53M ﹤0.01% 5376
2023
Q4
$383K Buy
6,900
+1,600
+30% +$72.2K ﹤0.01% 8659
2023
Q3
$190K Buy
5,300
+1,400
+36% +$48.3K ﹤0.01% 9997
2023
Q2
$123K Sell
3,900
-9,200
-70% -$352K ﹤0.01% 10606
2023
Q1
$404K Buy
13,100
+2,800
+27% +$84.9K ﹤0.01% 8753
2022
Q4
$319K Buy
+10,300
New +$236K ﹤0.01% 9180

Other funds holding ACLX

Citadel Advisors's ACLX Position: Q2 2026 in Review

Citadel Advisors sold out of Arcellx (ACLX) in Q2 2026, closing a stake of 21,806 shares — an estimated $2.5M sold.

Citadel Advisors first reported a position in ACLX in Q1 2022 and held it in 16 quarters. The position peaked at $97.8M in Q4 2025. 2 funds tracked by Wall St. Rank hold ACLX as of Q2 2026.

  • Citadel Advisors reported no remaining Arcellx position as of Q2 2026 after selling out during the quarter.
  • Citadel Advisors sold 21,806 Arcellx shares in Q2 2026, an estimated $2.5M.
  • Citadel Advisors first reported a position in Arcellx in Q1 2022 and held it in 16 quarters.
  • Citadel Advisors's Arcellx position peaked at $97.8M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Arcellx as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.